Association Between Obesity and Circulating Tumor Cells in Early Breast Cancer Patients (2023) Tzschaschel M, Friedl TW, Schochter F, Schütze S, Polasik A, Fehm T, Pantel K, et al. Journal article Quality-Adjusted Survival with Ribociclib Plus Fulvestrant Versus Placebo Plus Fulvestrant in Postmenopausal Women with HR±HER2− Advanced Breast Cancer in the MONALEESA-3 Trial (2022) Jerusalem G, Delea TE, Martin M, De Laurentiis M, Nusch A, Beck JT, Chan A, et al. Journal article Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study (2018) Mutschler NS, Scholz C, Friedl TWP, Zwingers T, Fasching P, Beckmann M, Fehm T, et al. Journal article Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial (2018) Hepp P, Fasching P, Beckmann M, Fehm T, Salmen J, Hagenbeck C, Jaeger B, et al. Journal article Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer (2017) Schramm A, Schochter F, Friedl TWP, De Greqorio N, Andergassen U, Alunni-Fabbroni M, Trapp E, et al. Journal article